Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Daesung Microbiological Labs, Inc. (036480:KRX), powered by AI.
Daesung Microbiological Labs, Inc. is currently trading at ₩6,570. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Daesung Microbiological Labs, Inc. on Alpha Lenz.
Daesung Microbiological Labs, Inc.'s P/E ratio is 41.7.
“Daesung Microbiological Labs, Inc. trades at a P/E of 41.7 (premium valuation) with modest ROE of 1.7%.”
Ask for details →Daesung Microbiological Labs, Inc. is a leading entity in the biotechnology and microbiological sectors, specializing in the development and production of biological products. The company's primary function centers around the research and manufacturing of a broad spectrum of microbiology-based solutions, which are crucial for industries such as pharmaceuticals, agriculture, and environmental health. Known for its innovative approach, Daesung Microbiological Labs harnesses advanced biotechnological processes to create effective and sustainable products that support public health and industrial applications. Its offerings are instrumental in enhancing agricultural productivity, ensuring food safety, and providing therapeutic solutions. In the financial markets, Daesung Microbiological Labs, Inc. plays a significant role by contributing to the biotech sector's growth and development. Its robust research capabilities and product portfolio position it as a key player in advancing scientific solutions that address global challenges, marking its presence in both domestic and international markets.
“Daesung Microbiological Labs, Inc. trades at a P/E of 41.7 (premium valuation) with modest ROE of 1.7%.”
Ask for details →Daesung Microbiological Labs, Inc. (ticker: 036480) is a company listed on KRX in the Healthcare sector (Biotechnology). Market cap is $25.0B.
The current price is ₩6,570 with a P/E ratio of 41.74x and P/B of 0.7x.
ROE is 1.70% and operating margin is 2.75%. Annual revenue is $26.0B.